Company Filing History:
Years Active: 1999
Title: Henning Bo Petersen: Innovator in Pharmaceutical Chemistry
Introduction
Henning Bo Petersen is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a valuable asset in the industry.
Latest Patents
Henning Bo Petersen holds a patent for a modified form of R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride. This invention is recognized for its pure and stable anhydrous form, which has potential applications in various therapeutic areas. His patent reflects his commitment to advancing pharmaceutical formulations.
Career Highlights
Petersen is associated with Novo Nordisk, a leading global healthcare company known for its focus on diabetes care and other chronic conditions. His work at Novo Nordisk has allowed him to contribute to groundbreaking research and development in the pharmaceutical sector. His innovative spirit and technical skills have been instrumental in driving projects forward.
Collaborations
Throughout his career, Henning Bo Petersen has collaborated with esteemed colleagues, including Preben Ahrndt and Vincent H. Chang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Henning Bo Petersen's contributions to pharmaceutical chemistry through his patent and work at Novo Nordisk highlight his role as an influential inventor. His dedication to innovation continues to impact the field positively.